Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$93.5K Buy
421
+2
+0.5% +$464 0.02% 160
2023
Q1
$101K Buy
419
+4
+1% +$982 0.02% 149
2022
Q4
$93.6K Hold
415
0.03% 118
2022
Q3
$94K Buy
415
+1
+0.2% +$242 0.03% 118
2022
Q2
$101K Buy
414
+2
+0.5% +$490 0.03% 115
2022
Q1
$100K Buy
412
+2
+0.5% +$460 0.02% 129
2021
Q4
$92K Buy
410
+2
+0.5% +$422 0.02% 136
2021
Q3
$87K Sell
408
-711
-64% -$164K 0.02% 139
2021
Q2
$273K Sell
1,119
-447
-29% -$110K 0.07% 63
2021
Q1
$390K Buy
1,566
+32
+2% +$7.63K 0.1% 41
2020
Q4
$353K Buy
1,534
+9
+0.6% +$2.08K 0.1% 44
2020
Q3
$389K Sell
1,525
-42
-3% -$10.4K 0.11% 35
2020
Q2
$405K Sell
1,567
-44
-3% -$10K 0.13% 34
2020
Q1
$326K Sell
1,611
-356
-18% -$77.8K 0.1% 38
2019
Q4
$474K Sell
1,967
-100
-5% -$22K 0.14% 44
2019
Q3
$400K Hold
2,067
0.14% 50
2019
Q2
$381K Sell
2,067
-179
-8% -$32.1K 0.14% 54
2019
Q1
$427K Sell
2,246
-53
-2% -$10.1K 0.19% 48
2018
Q4
$448K Buy
+2,299
New +$449K 0.26% 48

Other funds holding AMGN

TimeScale Financial's AMGN Position: Q2 2023 in Review

TimeScale Financial increased its Amgen (AMGN) stake by 0.48% in Q2 2023, buying an estimated $464 and bringing the position to 421 shares worth $93.5K. The position accounts for 0.02% of the portfolio, ranked #160.

TimeScale Financial first reported a position in AMGN in Q4 2018 and has held it in 19 quarters since. The position peaked at $474K in Q4 2019. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • TimeScale Financial held 421 shares of Amgen worth $93.5K as of Q2 2023.
  • TimeScale Financial bought 2 Amgen shares in Q2 2023, an estimated $464.
  • Amgen made up 0.02% of TimeScale Financial's portfolio in Q2 2023, its #160 holding.
  • TimeScale Financial first reported a position in Amgen in Q4 2018 and has held it in 19 quarters since.
  • TimeScale Financial's Amgen position peaked at $474K in Q4 2019.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.